Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Committee Legislation topic
No spam. Unsubscribe anytime.
Medical Affairs committee advances informed-consent, kratom and long‑term care visitation measures; several amendments adopted
Summary
The committee approved amendments and voted to advance multiple bills, including S-54 (medical informed-consent provisions), a kratom consumer-protection measure and a long-term-care visitation measure; votes on the bills were taken in committee and amendments were adopted as described below.
The Senate Medical Affairs Committee on Thursday advanced several bills and adopted multiple amendments after subcommittee hearings and debate. Committee members said they sought to balance individual liberties against public-health authority when drafting changes to emergency powers, medical informed-consent rules and product regulation.
Key committee actions (committee vote outcomes recorded at the hearing):
- Medical Informed Consent legislation (filed as S-54 in committee materials): the committee adopted technical and substantive amendments in subcommittee and on the floor and voted to report the bill favorably to the full Senate. Sponsors and subcommittee members said the bill clarifies informed-consent requirements, limits certain quarantine timeframes in statute, and restricts mandatory vaccine or gene-therapy requirements in employment and some institutional contexts while preserving the state’s ability to respond to true public-health emergencies.
- Kratom Consumer Protection-style measure (agenda item discussed in tab 2; bill cited in committee materials): the committee adopted an amendment that tightened the chemical-definition language and adjusted penalties to avoid unintended marketplace capture by single manufacturers; the amendment and underlying measure advanced out of committee.
- Long-term care visitation bill (S-146): the committee approved language to require long-term care facilities to permit at least one designated visitor for residents during emergency orders, and subcommittee-negotiated language expanded the visitor list and allowed limited annual changes; the bill was moved forward.
Committee members emphasized the bills do not prevent health officials or private entities from recommending vaccines, treatments or mitigation measures; proponents said the bills address civil-liberties concerns about indefinite quarantine authority and mandatory medical interventions. Opponents in the hearing urged caution and warned against limiting tools that public-health officials might need for high-risk diseases.
Votes on these measures were recorded in committee; several amendments were adopted by voice or roll-call vote and the measures were reported out to the Senate with the committee’s recommendations. Detailed amendments included changes to informed-consent wording, pharmacist-refusal procedures and age thresholds for consent language.
Ending: The committee’s action moves the bills to the next stage of consideration in the Senate; the measures will be scheduled for floor consideration per Senate rules and may be subject to further amendment.
